HepaGam B
NDC 49591-052 · Kamada Ltd.
Generic nameHUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
Dosage formINJECTION, SOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
Strength312 [iU]/mL
Pharmacologic classHuman Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]
Marketing categoryBLA
Packages
49591-052-51 — 1 VIAL, GLASS in 1 CARTON (49591-052-51) / 1 mL in 1 VIAL, GLASS (49591-052-11)
Billed under HCPCS
J1571 — Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml Medicare Part B payment limit (ASP + 6%): $65.61
J1573 — Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml Medicare Part B payment limit (ASP + 6%): $65.61
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
13533-636 — HEPATITIS B IMMUNE GLOBULIN (HUMAN), 49591-051 — HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN, 69800-4203 — Hepatitis B Immune Globulin (Human)